Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-०.२१%
१,०९१.५१
-२.३०
-०.२१%
—१,०९३.८११,०९६.५२१,१००.२२१,०९१.५१——
SIXC
Communications
SIXC
Communications
SIXC
+०.२२%
६१०.११
+१.३४
+०.२२%
—६०८.७७६०८.७७६१२.९७६०८.७७——
SIXE
Energy
SIXE
Energy
SIXE
-१.३४%
१,२३७.९८
-१६.८३
-१.३४%
—१,२५४.८११,२५३.०११,२५३.८७१,२२६.३३——
SIXI
Industrials
SIXI
Industrials
SIXI
-०.९३%
१,७४४.७१
-१६.४०
-०.९३%
—१,७६१.१११,७६४.२७१,७६६.८८१,७४४.७१——
SIXM
Financials
SIXM
Financials
SIXM
-०.३७%
६४०.१८
-२.४०
-०.३७%
—६४२.५८६४४.८७६४८.४८६४०.१८——
SIXR
Staples
SIXR
Staples
SIXR
-०.१८%
८४९.५८
-१.५५
-०.१८%
—८५१.१३८५५.६६८५८.७५८४५.५६——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-०.२३%
२१७.४८
-०.५०
-०.२३%
—२१७.९८२१७.९८२१८.६५२१६.८८——
SIXT
Technology
SIXT
Technology
SIXT
+१.५२%
३,२६०.६९
+४८.८६
+१.५२%
—३,२११.८३३,२२७.२१३,२६८.३८३,२२६.५५——
SIXU
Utilities
SIXU
Utilities
SIXU
-०.६९%
९४२.४५
-६.५३
-०.६९%
—९४८.९८९४८.५८९५७.८३९४१.९७——
SIXV
Health care
SIXV
Health care
SIXV
-०.५२%
१,४६६.८०
-७.७२
-०.५२%
—१,४७४.५२१,४७९.०३१,४८१.०४१,४६६.८०——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.२२%
२,३९७.५०
+५.३८
+०.२२%
—२,३९२.१२२,३९६.९५२,४२१.२२२,३८२.३२——
4559:TYO
Zeria Pharmaceutical Co Ltd
JP¥ २,१३२.००
-१.२५%
(-२७.००) 1D
मे १, १५:३०:०० GMT+९  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4559...
Open
JP¥ २,१५५
High
JP¥ २,१५६
Low
JP¥ २,१२३
Mkt. cap
१.०७ खरब
Avg. vol.
९६.१२ हजार
Volume
५४.०० हजार
Dividend
२.२५%
Quarterly dividend
JP¥ १२
Ex dividend date
२०२५ सेप्टेम्बर २९
P/E ratio
१२.९४
52-wk high
JP¥ २,३७८
52-wk low
JP¥ १,८७८
EPS
JP¥ १६५
Shares outstanding
५.०१ करोड
No. of employees
२ हजार
News stories
From sources across the web
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG. In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK. In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988. In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries, It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma. The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries. The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees१.७५ हजार
Founded१९५५ डिसेम्बर २२
Headquarters-
Sector-
Websitezeria.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
२०२५ मार्च
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
Revenue
२२.५४ अरब
१९.४९ अरब
२०.४७ अरब
२४.१२ अरब
Cost of goods sold
६.०५ अरब
५.५८ अरब
५.५९ अरब
६.३८ अरब
Cost of revenue
६.०५ अरब
५.५८ अरब
५.५९ अरब
६.३८ अरब
Research and development expenses
४.११ अरब
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.५८ अरब
१२.३९ अरब
१२.७६ अरब
१२.८२ अरब
Operating expense
१४.५४ अरब
१२.३९ अरब
१२.७६ अरब
१२.८२ अरब
Total operating expenses
२०.५९ अरब
१७.९७ अरब
१८.३५ अरब
१९.१९ अरब
Operating income
१.९५ अरब
१.५२ अरब
२.१२ अरब
४.९३ अरब
Other non operating income
-५.१० करोड
२.५० करोड
-२.३० करोड
-८.१० करोड
EBT including unusual items
२.१६ अरब
१.६६ अरब
९९.४० करोड
४.६३ अरब
EBT excluding unusual items
२.१८ अरब
१.६६ अरब
९९.४० करोड
४.६३ अरब
Income tax expense
३९.७० करोड
६२.४० करोड
३८.३० करोड
७९.५४ करोड
Effective tax rate
१८.३४%
३७.६१%
३८.५३%
-
Other operating expenses
-
-
-
-
Net income
१.७१ अरब
१.०९ अरब
६४.७० करोड
३.८२ अरब
Net profit margin
७.५९%
५.५९%
३.१६%
-
Earnings per share
-
-
-
-
Interest and investment income
९.५० करोड
२७.९० करोड
३.०० करोड
१३.६७ करोड
Interest expense
-११.४० करोड
-१२.१० करोड
-११.९० करोड
-१२.३० करोड
Net interest expenses
-१.९० करोड
१५.८० करोड
-८.९० करोड
१.३७ करोड
Depreciation and amortization charges
५.८५ अरब
-
-
-
EBITDA
३.८४ अरब
३.४१ अरब
३.८८ अरब
६.८१ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer